glp 1 age restrictions How young is too young for GLP-1s? Bariatric surgery? Academic experts offer insights GLP-1 Survey: 37.5% of People

Jain (AstraZeneca, Cambridge, UK) for critical review and comments on the manuscript during preparation

By combining semaglutide with cagrilintide (an amylin receptor agonist), this therapy has delivered weight loss results exceeding 20% in clinical trials

However, the absence of fibre may lead to changes in gut microbiome composition, which could have long-term consequences

Fluoroquinolones (ciprofloxacin, levofloxacin) and macrolides (azithromycin) show the most notable absorption changes due to delayed gastric emptying from tirzepatide

DPP-4 inhibitors: DPP-4 inhibitors are drugs that prevent the degradation of incretin hormones, such as GLP-1 (an incretin hormone that actively contributes to blood sugar control) in the DPP-4 rich incretin pathway